'Inverse vaccines': promise of a 'holy grail' treatment for autoimmune diseases

a year ago

Autoimmune diseases affect around 10% of the global population, with conditions like multiple sclerosis, lupus, and type 1 diabetes.
Current treatments suppress the entire immune system, leaving patients vulnerable to other illnesses.
Inverse vaccines target only the rogue part of the immune system, offering a more precise treatment approach.
A 2021 study showed inverse vaccines effectively protected celiac patients from gluten-induced intestinal damage.
Inverse vaccines use synthetic nanoparticles to retrain the immune system to ignore specific disease-related proteins.
Research in mice has shown promise for treating multiple sclerosis and allergies using inverse vaccines.
Inverse vaccines may provide long-lasting effects, similar to traditional vaccines, reducing the need for daily treatments.
Potential applications extend beyond autoimmunity to allergies, such as peanut allergies and alpha-gal syndrome.
Several biotech startups and pharmaceutical companies are investing in inverse vaccine development.
First inverse vaccines could be available in 3-10 years, with ongoing phase two trials.

Hasty Briefsbeta